A recent phase II clinical trial1 partially funded by ExcelVite (Chemor, Malaysia) found that a tocotrienol-rich vitamin E (EVNol SupraBio from ExcelVite) may support the conduction velocity of median and sural sensory nerves among type 2 diabetics. Diabetic peripheral neuropathy affects approximately 50% of type 2 diabetics in their lifetime. It causes nerve damage in patients that can lead to impaired mobility and quality of life.
